{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:02:29Z","timestamp":1784289749371,"version":"3.55.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Justus-Liebig-Universit\u00e4t Gie\u00dfen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Fascioliasis is a zoonosis and neglected tropical disease with worldwide distribution and significant economic impact. The search for anthelmintic compounds against\n                      <jats:italic>Fasciola hepatica<\/jats:italic>\n                      , one of the parasitic liver flukes responsible for this disease, has become important due to widespread resistances against existing drugs. To facilitate drug discovery, a useful strategy is the identification of proteins that are vital for the parasite. Protein kinases (PKs) emerged as potential targets in several parasites, given their critical role in many biological processes. To date, knowledge of the PKs present in\n                      <jats:italic>F. hepatica<\/jats:italic>\n                      is fragmentary.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We curated and classified the kinome of\n                      <jats:italic>F. hepatica<\/jats:italic>\n                      using a refined bioinformatics pipeline and found 245 PKs, which represented 2.14% of the parasite\u2019s proteome. Classification of all PKs into their families and sub-families revealed the CMGC group as the largest PK group. A comparison of the kinomes of\n                      <jats:italic>F. hepatica<\/jats:italic>\n                      with medically important\n                      <jats:italic>Schistosoma<\/jats:italic>\n                      species and the human host revealed key similarities and differences. Based on orthology to human sequences, KEGG functional annotation predicted that 25% of 110 annotated PKs in\n                      <jats:italic>F. hepatica<\/jats:italic>\n                      are involved in cancer pathways. We prioritized a panel of related, small-molecule PK inhibitors to assess their efficacy against different\n                      <jats:italic>F. hepatica<\/jats:italic>\n                      life stages in vitro. Among these, vandetanib and ruboxistaurin showed lethal effects on immature flukes in vitro at 50\u00a0\u00b5M concentration, and ruboxistaurin significantly reduced the motility of adult liver flukes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      These findings suggest that repurposing small-molecule PK inhibitors could be a good strategy for obtaining compounds to combat fascioliasis. The newly established\n                      <jats:italic>F. hepatica<\/jats:italic>\n                      kinome represents a resource for future target discovery.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12864-025-12513-w","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:54:25Z","timestamp":1768571665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Curation of the Fasciola hepatica kinome as a resource for drug target discovery"],"prefix":"10.1186","volume":"27","author":[{"given":"Sagar","family":"Ajmera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Puckelwaldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas J.","family":"Stroehlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Haeberlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"12513_CR1","doi-asserted-by":"crossref","unstructured":"Dalton JP, editor. Fasciolosis. In Fasciolosis, 2nd edition. . CABI International; 2021;1-501.","DOI":"10.1079\/9781789246162.0000"},{"key":"12513_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.micpath.2017.06.006","volume":"109","author":"K Mehmood","year":"2017","unstructured":"Mehmood K, Zhang H, Sabir AJ, Abbas RZ, Ijaz M, Durrani AZ, et al. A review on epidemiology, global prevalence and economical losses of fasciolosis in ruminants. Microb Pathog. 2017;109:253\u201362.","journal-title":"Microb Pathog"},{"key":"12513_CR3","unstructured":"World Health Organization. Integrating neglected tropical diseases into global health and development: Fourth WHO report on neglected tropical diseases. Geneva. 2017:193\u20136."},{"key":"12513_CR4","doi-asserted-by":"crossref","unstructured":"Cancela M, Maggioli G, editors. Fasciola hepatica: Methods and Protocols. Humana Press New York, NY; 2020:1\u2013235.","DOI":"10.1007\/978-1-0716-0475-5_18"},{"issue":"1","key":"12513_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijpddr.2013.11.005","volume":"4","author":"YM Brockwell","year":"2014","unstructured":"Brockwell YM, Elliott TP, Anderson GR, Stanton R, Spithill TW, Sangster NC. Confirmation of Fasciola hepatica resistant to triclabendazole in naturally infected Australian beef and dairy cattle. Int J Parasitol Drugs Drug Resist. 2014;4(1):48\u201354.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"6","key":"12513_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.pt.2016.03.002","volume":"32","author":"JM Kelley","year":"2016","unstructured":"Kelley JM, Elliott TP, Beddoe T, Anderson G, Skuce P, Spithill TW. Current threat of triclabendazole resistance in Fasciola hepatica. Trends Parasitol. 2016;32(6):458\u201369.","journal-title":"Trends Parasitol"},{"issue":"1","key":"12513_CR7","doi-asserted-by":"publisher","first-page":"e1011081","DOI":"10.1371\/journal.ppat.1011081","volume":"19","author":"NJ Beesley","year":"2023","unstructured":"Beesley NJ, Cwiklinski K, Allen K, Hoyle RC, Spithill TW, James La Course E, et al. A major locus confers triclabendazole resistance in Fasciola hepatica and shows dominant inheritance. PLoS Pathog. 2023;19(1):e1011081.","journal-title":"PLoS Pathog"},{"key":"12513_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ijpddr.2023.11.001","volume":"23","author":"A Kahl","year":"2023","unstructured":"Kahl A, von Samson-Himmelstjerna G, Helm C, Hodgkinson J, Williams D, Weiher W, et al. Efficacy of flukicides against Fasciola hepatica and first report of triclabendazole resistance on German sheep farms. Int J Parasitol Drugs Drug Resist. 2023;23:94\u2013105.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"1","key":"12513_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/14789450.2020.1719835","volume":"17","author":"N Arora","year":"2020","unstructured":"Arora N, Raj A, Anjum F, Kaur R, Rawat SS, Kumar R, et al. Unveiling Taenia solium kinome profile and its potential for new therapeutic targets. Expert Rev Proteomics. 2020;17(1):85\u201394.","journal-title":"Expert Rev Proteomics"},{"issue":"10","key":"12513_CR10","doi-asserted-by":"publisher","first-page":"e1006515","DOI":"10.1371\/journal.pcbi.1006515","volume":"14","author":"S Giuliani","year":"2018","unstructured":"Giuliani S, Silva AC, Borba JVVB, Ramos PIP, Paveley RA, Muratov EN, et al. Computationally-guided drug repurposing enables the discovery of kinase targets and inhibitors as new schistosomicidal agents. PLoS Comput Biol. 2018;14(10):e1006515.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"12513_CR11","doi-asserted-by":"publisher","first-page":"17759","DOI":"10.1038\/srep17759","volume":"5","author":"AJ Stroehlein","year":"2015","unstructured":"Stroehlein AJ, Young ND, Jex AR, Sternberg PW, Tan P, Boag PR, et al. Defining the Schistosoma haematobium kinome enables the prediction of essential kinases as anti-schistosome drug targets. Sci Rep. 2015;5(1):17759.","journal-title":"Sci Rep"},{"issue":"3","key":"12513_CR12","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.pt.2017.12.001","volume":"34","author":"CG Grevelding","year":"2018","unstructured":"Grevelding CG, Langner S, Dissous C. Kinases: molecular stage directors for schistosome development and differentiation. Trends Parasitol. 2018;34(3):246\u201360.","journal-title":"Trends Parasitol"},{"issue":"1","key":"12513_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12864-022-08457-0","volume":"23","author":"J Adderley","year":"2022","unstructured":"Adderley J, Doerig C. Comparative analysis of the kinomes of Plasmodium falciparum, Plasmodium vivax and their host Homo sapiens. BMC Genomics. 2022;23(1):237.","journal-title":"BMC Genomics"},{"key":"12513_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.csbj.2019.02.005","volume":"17","author":"JVB Borba","year":"2019","unstructured":"Borba JVB, Silva AC, Ramos PIP, Grazzia N, Miguel DC, Muratov EN, et al. Unveiling the kinomes of Leishmania infantum and L. braziliensis empowers the discovery of new kinase targets and antileishmanial compounds. Comput Struct Biotechnol J. 2019;17:352\u201361.","journal-title":"Comput Struct Biotechnol J"},{"key":"12513_CR15","doi-asserted-by":"crossref","unstructured":"Manning G, Whyte D, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002;298(5600):1992\u201334.","DOI":"10.1126\/science.1075762"},{"key":"12513_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2015.07.010","volume":"100","author":"R Roskoski","year":"2015","unstructured":"Roskoski R. A historical overview of protein kinases and their targeted small molecule inhibitors. Pharmacol Res. 2015;100:1\u201323.","journal-title":"Pharmacol Res"},{"issue":"4","key":"12513_CR17","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/molecules23040908","volume":"23","author":"F Carles","year":"2018","unstructured":"Carles F, Bourg S, Meyer C, Bonnet P. PKIDB: a curated, annotated and updated database of protein kinase inhibitors in clinical trials. Molecules. 2018;23(4):908.","journal-title":"Molecules"},{"issue":"14","key":"12513_CR18","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.3390\/molecules25143226","volume":"25","author":"C Bournez","year":"2020","unstructured":"Bournez C, Carles F, Peyrat G, Aci-S\u00e8che S, Bourg S, Meyer C, et al. Comparative assessment of protein kinase inhibitors in public databases and in PKIDB. Molecules. 2020;25(14):3226.","journal-title":"Molecules"},{"issue":"2","key":"12513_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.pt.2010.09.001","volume":"27","author":"C Dissous","year":"2011","unstructured":"Dissous C, Grevelding CG. Piggy-backing the concept of cancer drugs for schistosomiasis treatment: a tangible perspective? Trends Parasitol. 2011;27(2):59\u201366.","journal-title":"Trends Parasitol"},{"key":"12513_CR20","doi-asserted-by":"publisher","first-page":"611270","DOI":"10.3389\/fvets.2020.611270","volume":"7","author":"CM Morawietz","year":"2020","unstructured":"Morawietz CM, Houhou H, Puckelwaldt O, Hehr L, Dreisbach D, Mokosch A, et al. Targeting kinases in Fasciola hepatica: Anthelminthic effects and tissue distribution of selected kinase inhibitors. Front Vet Sci. 2020;7:611270.","journal-title":"Front Vet Sci"},{"issue":"1","key":"12513_CR21","doi-asserted-by":"publisher","first-page":"15867","DOI":"10.1038\/s41598-019-52416-x","volume":"9","author":"H Houhou","year":"2019","unstructured":"Houhou H, Puckelwaldt O, Strube C, Haeberlein S. Reference gene analysis and its use for kinase expression profiling in Fasciola hepatica. Sci Rep. 2019;9(1):15867.","journal-title":"Sci Rep"},{"key":"12513_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.molbiopara.2016.11.005","volume":"215","author":"KL Howe","year":"2017","unstructured":"Howe KL, Bolt BJ, Shafie M, Kersey P, Berriman M. WormBase ParaSite \u2212 a comprehensive resource for helminth genomics. Mol Biochem Parasitol. 2017;215:2\u201310.","journal-title":"Mol Biochem Parasitol"},{"issue":"19","key":"12513_CR23","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1093\/bioinformatics\/btt419","volume":"29","author":"JM Goldberg","year":"2013","unstructured":"Goldberg JM, Griggs AD, Smith JL, Haas BJ, Wortman JR, Zeng Q. Kinannote, a computer program to identify and classify members of the eukaryotic protein kinase superfamily. Bioinformatics. 2013;29(19):2387\u201394.","journal-title":"Bioinformatics"},{"key":"12513_CR24","first-page":"1","volume":"20","author":"M Wang","year":"2019","unstructured":"Wang M, Kong L. Pblat: a multithread blat algorithm speeding up aligning sequences to genomes. BMC Bioinformatics. 2019;20:1\u20134.","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"12513_CR25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan AR, Hall IM. BEDtools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26(6):841\u20132.","journal-title":"Bioinformatics"},{"issue":"1","key":"12513_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-6-31","volume":"6","author":"GSC Slater","year":"2005","unstructured":"Slater GSC, Birney E. Automated generation of heuristics for biological sequence comparison. BMC Bioinformatics. 2005;6(1):1\u201311.","journal-title":"BMC Bioinformatics"},{"key":"12513_CR27","doi-asserted-by":"crossref","unstructured":"Pertea G, Pertea M. GFF utilities: GffRead and GffCompare. F1000Res. 2020;9.: ISCB Comm J-304.","DOI":"10.12688\/f1000research.23297.2"},{"issue":"9","key":"12513_CR28","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1101\/gr.1224503","volume":"13","author":"L Li","year":"2003","unstructured":"Li L, Stoeckert CJ, Roos DS. OrthoMCL: identification of ortholog groups for eukaryotic genomes. Genome Res. 2003;13(9):2178\u201389.","journal-title":"Genome Res"},{"issue":"1","key":"12513_CR29","first-page":"6","volume":"35","author":"S Fischer","year":"2011","unstructured":"Fischer S, Brunk BP, Chen F, Gao X, Harb OS, Iodice JB, et al. Using OrthoMCL to assign proteins to OrthoMCL-DB groups or to cluster proteomes into new ortholog groups. Curr Protoc Bioinformatics. 2011;35(1):6\u201312.","journal-title":"Curr Protoc Bioinformatics"},{"issue":"9","key":"12513_CR30","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/bioinformatics\/btu031","volume":"30","author":"P Jones","year":"2014","unstructured":"Jones P, Binns D, Chang HY, Fraser M, Li W, McAnulla C, et al. InterProScan 5: genome-scale protein function classification. Bioinformatics. 2014;30(9):1236\u201340.","journal-title":"Bioinformatics"},{"issue":"D1","key":"12513_CR31","doi-asserted-by":"publisher","first-page":"D412","DOI":"10.1093\/nar\/gkaa913","volume":"49","author":"J Mistry","year":"2021","unstructured":"Mistry J, Chuguransky S, Williams L, Qureshi M, Salazar GA, Sonnhammer ELL, et al. Pfam: The protein families database in 2021. Nucleic Acids Res. 2021;49(D1):D412\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"12513_CR32","doi-asserted-by":"publisher","first-page":"D394","DOI":"10.1093\/nar\/gkaa1106","volume":"49","author":"H Mi","year":"2021","unstructured":"Mi H, Ebert D, Muruganujan A, Mills C, Albou LP, Mushayamaha T, et al. PANTHER version 16: A revised family classification, tree-based classification tool, enhancer regions and extensive API. Nucleic Acids Res. 2021;49(D1):D394-403.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"12513_CR33","doi-asserted-by":"publisher","first-page":"D490","DOI":"10.1093\/nar\/gky1130","volume":"47","author":"AP Pandurangan","year":"2019","unstructured":"Pandurangan AP, Stahlhacke J, Oates ME, Smithers B, Gough J. The SUPERFAMILY 2.0 database: a significant proteome update and a new webserver. Nucleic Acids Res. 2019;47(D1):D490\u20134.","journal-title":"Nucleic Acids Res"},{"key":"12513_CR34","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2023. https:\/\/www.R-project.org\/"},{"issue":"43","key":"12513_CR35","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Averick M, Bryan J, Chang W, McGowan L, Fran\u00e7ois R, et al. Welcome to the Tidyverse. J Open Source Softw. 2019;4(43):1686.","journal-title":"J Open Source Softw"},{"issue":"4","key":"12513_CR36","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/molbev\/mst010","volume":"30","author":"K Katoh","year":"2013","unstructured":"Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013;30(4):772\u201380.","journal-title":"Mol Biol Evol"},{"issue":"1","key":"12513_CR37","doi-asserted-by":"publisher","first-page":"6968","DOI":"10.1038\/s41467-022-34630-w","volume":"13","author":"RC Edgar","year":"2022","unstructured":"Edgar RC. Muscle5: high-accuracy alignment ensembles enable unbiased assessments of sequence homology and phylogeny. Nat Commun. 2022;13(1):6968.","journal-title":"Nat Commun"},{"issue":"3","key":"12513_CR38","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/sysbio\/sys029","volume":"61","author":"F Ronquist","year":"2012","unstructured":"Ronquist F, Teslenko M, Van Der Mark P, Ayres DL, Darling A, H\u00f6hna S, et al. Mrbayes 3.2: efficient bayesian phylogenetic inference and model choice across a large model space. Syst Biol. 2012;61(3):539\u201342.","journal-title":"Syst Biol"},{"issue":"4","key":"12513_CR39","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jmb.2015.11.006","volume":"428","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa M, Sato Y, Morishima K. Blastkoala and ghostkoala: KEGG tools for functional characterization of genome and metagenome sequences. J Mol Biol. 2016;428(4):726\u201331.","journal-title":"J Mol Biol"},{"key":"12513_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-12-215","volume":"12","author":"LF Andrade","year":"2011","unstructured":"Andrade LF, Nahum LA, Avelar LGA, Silva LL, Zerlotini A, Ruiz JC, et al. Eukaryotic protein kinases (ePKs) of the helminth parasite Schistosoma mansoni. BMC Genomics. 2011;12:1\u20139.","journal-title":"BMC Genomics"},{"issue":"SUPPL. 2","key":"12513_CR41","doi-asserted-by":"publisher","first-page":"W29","DOI":"10.1093\/nar\/gkr367","volume":"39","author":"RD Finn","year":"2011","unstructured":"Finn RD, Clements J, Eddy SR. HMMER web server: interactive sequence similarity searching. Nucleic Acids Res. 2011;39(SUPPL. 2):W29-37.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"12513_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-019-1832-y","volume":"20","author":"DM Emms","year":"2019","unstructured":"Emms DM, Kelly S. Orthofinder: phylogenetic orthology inference for comparative genomics. Genome Biol. 2019;20(1):1\u201314.","journal-title":"Genome Biol"},{"issue":"W1","key":"12513_CR43","doi-asserted-by":"publisher","first-page":"W521","DOI":"10.1093\/nar\/gkae241","volume":"52","author":"F Madeira","year":"2024","unstructured":"Madeira F, Madhusoodanan N, Lee J, Eusebi A, Niewielska A, Tivey ARN, et al. The EMBL-EBI job dispatcher sequence analysis tools framework in 2024. Nucleic Acids Res. 2024;52(W1):W521\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"12513_CR44","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","volume":"215","author":"SF Altschul","year":"1990","unstructured":"Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215(3):403\u201310.","journal-title":"J Mol Biol"},{"issue":"11","key":"12513_CR45","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.tips.2019.09.002","volume":"40","author":"GK Kanev","year":"2019","unstructured":"Kanev GK, de Graaf C, de Esch IJP, Leurs R, W\u00fcrdinger T, Westerman BA, et al. The landscape of atypical and eukaryotic protein kinases. Trends Pharmacol Sci. 2019;40(11):818\u201332.","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"12513_CR46","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1096\/fasebj.9.8.7768349","volume":"9","author":"SK Hanks","year":"1995","unstructured":"Hanks SK, Hunter T. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 1995;9(8):576\u201396.","journal-title":"FASEB J"},{"issue":"15","key":"12513_CR47","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.3390\/cancers15153838","volume":"15","author":"I Chowdhury","year":"2023","unstructured":"Chowdhury I, Dashi G, Keskitalo S. CMGC kinases in health and cancer. Cancers (Basel). 2023;15(15):3838.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"12513_CR48","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1042\/BST20180480","volume":"46","author":"SSK Nawaratna","year":"2018","unstructured":"Nawaratna SSK, You H, Jones MK, McManus DP, Gobert GN. Calcium and Ca 2+ \/calmodulin-dependent kinase II as targets for helminth parasite control. Biochem Soc Trans. 2018;46(6):1743\u201351.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"12513_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrm2822","volume":"11","author":"LR Pearce","year":"2010","unstructured":"Pearce LR, Komander D, Alessi DR. The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol. 2010;11(1):9\u201322.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"12513_CR50","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1146\/annurev.biochem.69.1.373","volume":"69","author":"SR Hubbard","year":"2000","unstructured":"Hubbard SR, Till JH. Protein tyrosine kinase structure and function. Annu Rev Biochem. 2000;69(1):373\u201398.","journal-title":"Annu Rev Biochem"},{"issue":"49","key":"12513_CR51","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1038\/sj.onc.1203957","volume":"19","author":"DR Robinson","year":"2000","unstructured":"Robinson DR, Wu YM, Lin SF. The protein tyrosine kinase family of the human genome. Oncogene. 2000;19(49):5548\u201357.","journal-title":"Oncogene"},{"issue":"D1","key":"12513_CR52","doi-asserted-by":"publisher","first-page":"D458","DOI":"10.1093\/nar\/gkaa937","volume":"49","author":"I Letunic","year":"2021","unstructured":"Letunic I, Khedkar S, Bork P. SMART: Recent updates, new developments and status in 2020. Nucleic Acids Res. 2021;49(D1):D458\u201360.","journal-title":"Nucleic Acids Res"},{"issue":"suppl_1","key":"12513_CR53","doi-asserted-by":"publisher","first-page":"D599","DOI":"10.1093\/nar\/gkm684","volume":"36","author":"SMC Robb","year":"2007","unstructured":"Robb SMC, Ross E, Alvarado AS. Smedgd: the schmidtea mediterranea genome database. Nucleic Acids Res. 2007;36(suppl_1):D599-606.","journal-title":"Nucleic Acids Res"},{"issue":"7690","key":"12513_CR54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature25473","volume":"554","author":"MA Grohme","year":"2018","unstructured":"Grohme MA, Schloissnig S, Rozanski A, Pippel M, Young GR, Winkler S, et al. The genome of Schmidtea mediterranea and the evolution of core cellular mechanisms. Nature. 2018;554(7690):56\u201361.","journal-title":"Nature"},{"issue":"1","key":"12513_CR55","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1038\/s41467-017-02214-8","volume":"8","author":"J Wudarski","year":"2017","unstructured":"Wudarski J, Simanov D, Ustyantsev K, De Mulder K, Grelling M, Grudniewska M, et al. Efficient transgenesis and annotated genome sequence of the regenerative flatworm model Macrostomum lignano. Nat Commun. 2017;8(1):2120.","journal-title":"Nat Commun"},{"issue":"16","key":"12513_CR56","first-page":"4645","volume":"62","author":"SR Wedge","year":"2002","unstructured":"Wedge SR, Ogilvie DJ, Dukes M, Kendrew J, Chester R, Jackson JA, et al. ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration. Cancer Res. 2002;62(16):4645\u201355.","journal-title":"Cancer Res"},{"issue":"14","key":"12513_CR57","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1021\/jm950588y","volume":"39","author":"MR Jirousek","year":"1996","unstructured":"Jirousek MR, Gillig JR, Gonzalez CM, Heath WF, Mcdonald Iii JH, Neel DA, et al. 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-dione (LY333531) and related analogues: Isozyme selective inhibitors of protein kinase C. J Med Chem. 1996;39(14):2664\u201371.","journal-title":"J Med Chem"},{"issue":"1","key":"12513_CR58","doi-asserted-by":"publisher","first-page":"8918","DOI":"10.1038\/s41467-024-53215-3","volume":"15","author":"S Gramberg","year":"2024","unstructured":"Gramberg S, Puckelwaldt O, Schmitt T, Lu Z, Haeberlein S. Spatial transcriptomics of a parasitic flatworm provides a molecular map of drug targets and drug resistance genes. Nat Commun. 2024;15(1):8918.","journal-title":"Nat Commun"},{"issue":"4","key":"12513_CR59","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1634\/theoncologist.2008-0261","volume":"14","author":"A Morabito","year":"2009","unstructured":"Morabito A, Piccirillo MC, Falasconi F, De Feo G, Del Giudice A, Bryce J, et al. Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: Current status and future directions. Oncologist. 2009;14(4):378\u201390.","journal-title":"Oncologist"},{"issue":"14","key":"12513_CR60","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1158\/1078-0432.CCR-11-2041","volume":"18","author":"K Inoue","year":"2012","unstructured":"Inoue K, Torimura T, Nakamura T, Iwamoto H, Masuda H, Abe M, et al. Vandetanib, an inhibitor of VEGF receptor-2 and EGF receptor, suppresses tumor development and improves prognosis of liver cancer in mice. Clin Cancer Res. 2012;18(14):3924\u201333.","journal-title":"Clin Cancer Res"},{"issue":"20","key":"12513_CR61","doi-asserted-by":"publisher","first-page":"8009","DOI":"10.1158\/0008-5472.CAN-08-4889","volume":"69","author":"F Qian","year":"2009","unstructured":"Qian F, Engst S, Yamaguchi K, Peiwen Y, Won KA, Mock L, et al. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases. Cancer Res. 2009;69(20):8009\u201316.","journal-title":"Cancer Res"},{"issue":"14","key":"12513_CR62","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1158\/0008-5472.CAN-10-2527","volume":"71","author":"WK You","year":"2011","unstructured":"You WK, Sennino B, Williamson CW, Falc\u00f3n B, Hashizume H, Yao LC, et al. VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer. Cancer Res. 2011;71(14):4758\u201368.","journal-title":"Cancer Res"},{"issue":"9","key":"12513_CR63","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/bioinformatics\/14.9.755","volume":"14","author":"SR Eddy","year":"1998","unstructured":"Eddy SR. Profile hidden Markov models. Bioinformatics. 1998;14(9):755\u201363.","journal-title":"Bioinformatics"},{"issue":"D1","key":"12513_CR64","doi-asserted-by":"publisher","first-page":"D348","DOI":"10.1093\/nar\/gks1243","volume":"41","author":"A Marchler-Bauer","year":"2013","unstructured":"Marchler-Bauer A, Zheng C, Chitsaz F, Derbyshire MK, Geer LY, Geer RC, et al. CDD: Conserved domains and protein three-dimensional structure. Nucleic Acids Res. 2013;41(D1):D348\u201352.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"12513_CR65","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.biotechadv.2018.02.013","volume":"36","author":"AJ Stroehlein","year":"2018","unstructured":"Stroehlein AJ, Young ND, Gasser RB. Advances in kinome research of parasitic worms - implications for fundamental research and applied biotechnological outcomes. Biotechnol Adv. 2018;36(4):915\u201334.","journal-title":"Biotechnol Adv"},{"issue":"7","key":"12513_CR66","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.3390\/ijms21072346","volume":"21","author":"J Yue","year":"2020","unstructured":"Yue J, L\u00f3pez JM. Understanding MAPK signaling pathways in apoptosis. Int J Mol Sci. 2020;21(7):2346.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"12513_CR67","doi-asserted-by":"publisher","first-page":"e2949","DOI":"10.1371\/journal.pntd.0002949","volume":"8","author":"LF de Andrade","year":"2014","unstructured":"de Andrade LF, de Mour\u00e3o MM, Geraldo JA, Coelho FS, Silva LL, Neves RH, et al. Regulation of Schistosoma mansoni development and reproduction by the mitogen-activated protein kinase signaling pathway. PLoS Negl Trop Dis. 2014;8(6):e2949.","journal-title":"PLoS Negl Trop Dis"},{"key":"12513_CR68","doi-asserted-by":"publisher","first-page":"913301","DOI":"10.3389\/fcimb.2022.913301","volume":"12","author":"BP Moreira","year":"2022","unstructured":"Moreira BP, Batista ICA, Tavares NC, Armstrong T, Gava SG, Torres GP, et al. Docking-based virtual screening enables prioritizing protein kinase inhibitors with in vitro phenotypic activity against Schistosoma mansoni. Front Cell Infect Microbiol. 2022;12:913301.","journal-title":"Front Cell Infect Microbiol"},{"key":"12513_CR69","doi-asserted-by":"publisher","first-page":"1494407","DOI":"10.3389\/fpara.2024.1394407","volume":"3","author":"BP Moreira","year":"2024","unstructured":"Moreira BP, Gava SG, Haeberlein S, Gueye S, Santos ESS, Weber MHW, et al. Identification of potent schistosomicidal compounds predicted as type II-kinase inhibitors against Schistosoma mansoni c-Jun N-terminal kinase SMJNK. Frontiers in Parasitology. 2024;3:1494407.","journal-title":"Frontiers in Parasitology"},{"issue":"2","key":"12513_CR70","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ceb.2007.02.010","volume":"19","author":"SR Hubbard","year":"2007","unstructured":"Hubbard SR, Miller WT. Receptor tyrosine kinases: mechanisms of activation and signaling. Curr Opin Cell Biol. 2007;19(2):117\u201323.","journal-title":"Curr Opin Cell Biol"},{"issue":"8","key":"12513_CR71","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.bbamcr.2007.01.002","volume":"1773","author":"M Katz","year":"2007","unstructured":"Katz M, Amit I, Yarden Y. Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim Biophys Acta Mol Cell Res. 2007;1773(8):1161\u201376.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"12513_CR72","doi-asserted-by":"publisher","first-page":"772510","DOI":"10.3389\/fphar.2021.772510","volume":"12","author":"S Sudhesh Dev","year":"2021","unstructured":"Sudhesh Dev S, Zainal Abidin SA, Farghadani R, Othman I, Naidu R. Receptor tyrosine kinases and their signaling pathways as therapeutic targets of curcumin in cancer. Front Pharmacol. 2021;12:772510.","journal-title":"Front Pharmacol"},{"key":"12513_CR73","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fendo.2014.00072","volume":"5","author":"C Dissous","year":"2014","unstructured":"Dissous C, Morel M, Vanderstraete M. Venus kinase receptors: prospects in signaling and biological functions of these invertebrate kinases. Front Endocrinol (Lausanne). 2014;5:72.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"12513_CR74","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fendo.2015.00118","volume":"6","author":"C Dissous","year":"2015","unstructured":"Dissous C. Venus kinase receptors at the crossroads of insulin signaling: their role in reproduction for helminths and insects. Front Endocrinol (Lausanne). 2015;6:118.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"12513_CR75","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0166-6851(02)00249-9","volume":"126","author":"J Vicogne","year":"2003","unstructured":"Vicogne J, Pin JP, Lardans V, Capron M, No\u00ebl C, Dissous C. An unusual receptor tyrosine kinase of Schistosoma mansoni contains a venus flytrap module. Mol Biochem Parasitol. 2003;126(1):51\u201362.","journal-title":"Mol Biochem Parasitol"},{"issue":"5","key":"12513_CR76","doi-asserted-by":"publisher","first-page":"e2226","DOI":"10.1371\/journal.pntd.0002226","volume":"7","author":"M Vanderstraete","year":"2013","unstructured":"Vanderstraete M, Gouignard N, Cailliau K, Morel M, Lancelot J, Bodart JF, et al. Dual targeting of insulin and venus kinase receptors of Schistosoma mansoni for novel anti-schistosome therapy. PLoS Negl Trop Dis. 2013;7(5):e2226.","journal-title":"PLoS Negl Trop Dis"},{"issue":"49","key":"12513_CR77","doi-asserted-by":"publisher","first-page":"42325","DOI":"10.1074\/jbc.M110.210336","volume":"286","author":"S Beckmann","year":"2011","unstructured":"Beckmann S, Hahnel S, Cailliau K, Vanderstraete M, Browaeys E, Dissous C, et al. Characterization of the Src\/Abl hybrid kinase SmTK6 of Schistosoma mansoni. J Biol Chem. 2011;286(49):42325\u201336.","journal-title":"J Biol Chem"},{"issue":"4","key":"12513_CR78","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/molecules27041414","volume":"27","author":"BP Moreira","year":"2022","unstructured":"Moreira BP, Weber MHW, Haeberlein S, Mokosch AS, Spengler B, Grevelding CG, et al. Drug repurposing and de novo drug discovery of protein kinase inhibitors as new drugs against schistosomiasis. Molecules. 2022;27(4):1414.","journal-title":"Molecules"},{"issue":"6","key":"12513_CR79","doi-asserted-by":"publisher","first-page":"737","DOI":"10.4155\/fmc.15.31","volume":"7","author":"V Gelmedin","year":"2015","unstructured":"Gelmedin V, Dissous C, Grevelding CG. Re-positioning protein-kinase inhibitors against schistosomiasis. Future Med Chem. 2015;7(6):737\u201352.","journal-title":"Future Med Chem"},{"key":"12513_CR80","doi-asserted-by":"crossref","unstructured":"Laufer S, editor. Proteinkinase inhibitors. 1st edition. Springer; 2021;1\u2013256.","DOI":"10.1007\/978-3-030-68180-7"},{"issue":"4","key":"12513_CR81","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1042\/EBC20220002","volume":"66","author":"CN Chu","year":"2022","unstructured":"Chu CN, Lee TKW. Targeting protein kinases in cancer stem cells. Essays Biochem. 2022;66(4):399\u2013412.","journal-title":"Essays Biochem"},{"key":"12513_CR82","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.gde.2016.06.010","volume":"40","author":"GR Wendt","year":"2016","unstructured":"Wendt GR, Collins JJ. Schistosomiasis as a disease of stem cells. Curr Opin Genet Dev. 2016;40:95\u2013102.","journal-title":"Curr Opin Genet Dev"},{"key":"12513_CR83","doi-asserted-by":"crossref","unstructured":"Klaeger S, Heinzlmeir S, Wilhelm M, Polzer H, Vick B, Koenig PA, et al. The target landscape of clinical kinase drugs. Science (1979). 2017;358(6367):eaan4368.","DOI":"10.1126\/science.aan4368"},{"issue":"2","key":"12513_CR84","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.str.2004.01.005","volume":"12","author":"D Komander","year":"2004","unstructured":"Komander D, Kular GS, Sch\u00fcttelkopf AW, Deak M, Prakash KRC, Bain J, et al. Interactions of LY333531 and other bisindolyl maleimide inhibitors with PDK1. Structure. 2004;12(2):215\u201326.","journal-title":"Structure"},{"key":"12513_CR85","doi-asserted-by":"publisher","first-page":"CMS5046","DOI":"10.4137\/CMT.S5046","volume":"2","author":"G Javey","year":"2010","unstructured":"Javey G, Schwartz SG, Flynn HW, Aiello LP, Sheetz MJ. Ruboxistaurin: review of safety and efficacy in the treatment of diabetic retinopathy. Clin Med Insights Ther. 2010;2:CMS5046.","journal-title":"Clin Med Insights Ther"},{"issue":"11","key":"12513_CR86","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3390\/pharmaceutics13111748","volume":"13","author":"T Kawano","year":"2021","unstructured":"Kawano T, Inokuchi J, Eto M, Murata M, Kang JH. Activators and inhibitors of protein kinase c (PKC): their applications in clinical trials. Pharmaceutics. 2021;13(11):1748.","journal-title":"Pharmaceutics"},{"issue":"3","key":"12513_CR87","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1167\/iovs.12-11055","volume":"54","author":"MJ Sheetz","year":"2013","unstructured":"Sheetz MJ, Aiello LP, Davis MD, Danis R, Bek T, Cunha-Vaz J, et al. The effect of the oral PKC\u03b2 inhibitor ruboxistaurin on vision loss in two phase 3 studies. Invest Ophthalmol Vis Sci. 2013;54(3):1750\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"12513_CR88","doi-asserted-by":"publisher","first-page":"7462","DOI":"10.4049\/jimmunol.166.12.7462","volume":"166","author":"MR Deehan","year":"2001","unstructured":"Deehan MR, Harnett W, Harnett MM. A filarial nematode-secreted phosphorylcholine-containing glycoprotein uncouples the B cell antigen receptor from extracellular signal-regulated kinase-mitogen-activated protein kinase by promoting the surface Ig-mediated recruitment of Src homology 2 domain-containing tyrosine phosphatase-1 and Pac-1 mitogen-activated kinase-phosphatase 1. J Immunol. 2001;166(12):7462\u20138.","journal-title":"J Immunol"},{"issue":"11","key":"12513_CR89","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1046\/j.1365-3024.1998.00181.x","volume":"20","author":"MM Harnett","year":"1998","unstructured":"Harnett MM, Deehan MR, Williams DM, Harnett W. Induction of signalling anergy via the T-cell receptor in cultured Jurkat T cells by pre-exposure to a filarial nematode secreted product. Parasite Immunol. 1998;20(11):551\u201363.","journal-title":"Parasite Immunol"},{"issue":"3","key":"12513_CR90","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1369\/0022155413517701","volume":"62","author":"BS Fogh","year":"2014","unstructured":"Fogh BS, Multhaupt HAB, Couchman JR. Protein kinase C, focal adhesions and the regulation of cell migration. J Histochem Cytochem. 2014;62(3):172\u201384.","journal-title":"J Histochem Cytochem"},{"issue":"6","key":"12513_CR91","doi-asserted-by":"publisher","first-page":"R2089","DOI":"10.1152\/ajpregu.2000.279.6.R2089","volume":"279","author":"MK Graham","year":"2000","unstructured":"Graham MK, Fairweather I, Mcgeown JG. Second messengers mediating mechanical responses to the FARP GYIRFamide in the fluke Fasciola hepatica. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2000;279(6):R2089\u201394.","journal-title":"American Journal of Physiology-Regulatory, Integrative and Comparative Physiology"},{"key":"12513_CR92","unstructured":"EMEA. Withdrawal assessment report for Arxxant-Ruboxistaurin (as mesilate monohydrate). London; 2007. Available from: http:\/\/www.emea.europa.eu."},{"issue":"6","key":"12513_CR93","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cytogfr.2015.04.001","volume":"26","author":"YO Kipryushina","year":"2015","unstructured":"Kipryushina YO, Yakovlev KV, Odintsova NA. Vascular endothelial growth factors: a comparison between invertebrates and vertebrates. Cytokine Growth Factor Rev. 2015;26(6):687\u201395.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"9","key":"12513_CR94","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1093\/molbev\/msn132","volume":"25","author":"S D\u2019Aniello","year":"2008","unstructured":"D\u2019Aniello S, Irimia M, Maeso I, Pascual-Anaya J, Jim\u00e9nez-Delgado S, Bertrand S, et al. Gene expansion and retention leads to a diverse tyrosine kinase superfamily in amphioxus. Mol Biol Evol. 2008;25(9):1841\u201354.","journal-title":"Mol Biol Evol"},{"issue":"2","key":"12513_CR95","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/annonc\/mdw559","volume":"28","author":"SH Lee","year":"2017","unstructured":"Lee SH, Lee JK, Ahn MJ, Kim DW, Sun JM, Keam B, et al. Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial. Ann Oncol. 2017;28(2):292\u20137.","journal-title":"Ann Oncol"},{"key":"12513_CR96","doi-asserted-by":"crossref","unstructured":"Horiike A, Yoh K, Seto T, Satouchi M, Nishio M, Yamamoto N, et al. NSCLC, metastatic 1203PD LURET study: Phase 2 study of vandetanib in patients with advanced RET-rearranged non-small cell lung cancer (NSCLC). Annals of Oncology. 2016;27:vi416\u201354.","DOI":"10.1093\/annonc\/mdw383.04"},{"issue":"2","key":"12513_CR97","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1124\/jpet.106.102376","volume":"318","author":"DL Gustafson","year":"2006","unstructured":"Gustafson DL, Bradshaw-Pierce EL, Merz AL, Zirrolli JA. Tissue distribution and metabolism of the tyrosine kinase inhibitor ZD6474 (zactima) in tumor-bearing nude mice following oral dosing. J Pharmacol Exp Ther. 2006;318(2):872\u201380.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"12513_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-015-1023-y","volume":"8","author":"N Cowan","year":"2015","unstructured":"Cowan N, Keiser J. Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni. Parasit Vectors. 2015;8(1):1\u20139.","journal-title":"Parasit Vectors"},{"issue":"6","key":"12513_CR99","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cvsm.2007.06.003","volume":"37","author":"CA London","year":"2007","unstructured":"London CA. The role of small molecule inhibitors for veterinary patients. Veterinary Clinics of North America - Small Animal Practice. 2007;37(6):1121\u201336.","journal-title":"Veterinary Clinics of North America - Small Animal Practice"},{"issue":"1","key":"12513_CR100","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s44356-025-00036-1","volume":"2","author":"FBC de Moura","year":"2025","unstructured":"de Moura FBC, Amorim RL, Fonseca-Alves CE. Tyrosine kinase inhibitors in canine solid tumours: a systematic review of indications, response and safety. Vet Oncol. 2025;2(1):21.","journal-title":"Vet Oncol"},{"issue":"12","key":"12513_CR101","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/infdis\/jiw488","volume":"214","author":"DA Schaefer","year":"2016","unstructured":"Schaefer DA, Betzer DP, Smith KD, Millman ZG, Michalski HC, Menchaca SE, et al. Novel bumped kinase inhibitors are safe and effective therapeutics in the calf clinical model for cryptosporidiosis. J Infect Dis. 2016;214(12):1856\u201364.","journal-title":"J Infect Dis"},{"issue":"1","key":"12513_CR102","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijpddr.2018.02.003","volume":"8","author":"R S\u00e1nchez-S\u00e1nchez","year":"2018","unstructured":"S\u00e1nchez-S\u00e1nchez R, Ferre I, Re M, V\u00e1zquez P, Ferrer LM, Blanco-Murcia J, et al. Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoites. Int J Parasitol Drugs Drug Resist. 2018;8(1):112\u201324.","journal-title":"Int J Parasitol Drugs Drug Resist"}],"container-title":["BMC Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12864-025-12513-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-025-12513-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-025-12513-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:03:51Z","timestamp":1769515431000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12864-025-12513-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12513"],"URL":"https:\/\/doi.org\/10.1186\/s12864-025-12513-w","relation":{},"ISSN":["1471-2164"],"issn-type":[{"value":"1471-2164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}